Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT00307047
Show Display Options
Rank Status Study
1 Completed
Has Results
SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System
Condition: Coronary Artery Disease
Interventions: Device: XIENCE V® Everolimus Eluting Coronary Stent;   Device: TAXUS™ EXPRESS2™ Paclitaxel Eluting Coronary Stent

Indicates status has not been verified in more than two years